435TiP Molecular imaging of programmed death ligand 1 (PD-L1) expression with [89Zr]Zr-atezolizumab positron emission tomography/computed tomography (PET/CT) in patients with metastatic triple negative breast cancer (mTNBC): The MIMIR-study

Autor: Altena, R., Tzortzakakis, A., Blomgren, A., Jussing, E., Ekman, S., Tran, T., Axelsson, R., Bergh, J.
Zdroj: In Annals of Oncology September 2024 35 Supplement 2:S402-S403
Databáze: ScienceDirect